CLINICAL RHEUMATOLOGY, vol.40, pp.4071-4079, 2021 (SCI-Expanded)
Objectives To compare the effectiveness of cyclophosphamide and rituximab in the treatment of patients with systemic sclerosis with pulmonary involvement (SSc-ILD).